AQP2 | Aquaporin 2 (collecting duct) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AQP6 | Aquaporin 6, kidney specific | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ATP6V0D2 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 | Predicted intracellular proteins
| | | | | Tissue enriched |
ATP6V1G3 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 | Predicted intracellular proteins Transporters
| | | | | Tissue enriched |
BBOX1 | Butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
BSND | Barttin CLCNK-type chloride channel accessory beta subunit | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
C9orf66 | Chromosome 9 open reading frame 66 | Predicted intracellular proteins
| | | | | Tissue enriched |
CALB1 | Calbindin 1, 28kDa | Predicted intracellular proteins
| | | | | Tissue enriched |
CDH16 | Cadherin 16, KSP-cadherin | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CLCN5 | Chloride channel, voltage-sensitive 5 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CLCNKA | Chloride channel, voltage-sensitive Ka | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
CLDN16 | Claudin 16 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CLEC18A | C-type lectin domain family 18, member A | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CLEC18B | C-type lectin domain family 18, member B | Predicted secreted proteins
| | | | | Tissue enriched |
CLEC18C | C-type lectin domain family 18, member C | Predicted secreted proteins
| | | | | Tissue enriched |
CRYAA | Crystallin, alpha A | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CRYAA | Crystallin, alpha A | Predicted intracellular proteins
| | | | | Tissue enriched |
CRYBB3 | Crystallin, beta B3 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enriched |
CTXN3 | Cortexin 3 | Predicted membrane proteins
| | | | | Tissue enriched |
CYS1 | Cystin 1 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enriched |
EMX1 | Empty spiracles homeobox 1 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
FMO1 | Flavin containing monooxygenase 1 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
FXYD4 | FXYD domain containing ion transport regulator 4 | Predicted membrane proteins
| | | | | Tissue enriched |
GALNT14 | Polypeptide N-acetylgalactosaminyltransferase 14 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
GGACT | Gamma-glutamylamine cyclotransferase | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
HMX2 | H6 family homeobox 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
KCNJ1 | Potassium inwardly-rectifying channel, subfamily J, member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
KL | Klotho | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
LHX1 | LIM homeobox 1 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
MCCD1 | Mitochondrial coiled-coil domain 1 | Mitochondrial proteins Predicted secreted proteins
| | | | | Tissue enriched |
MIOX | Myo-inositol oxygenase | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
NAT8 | N-acetyltransferase 8 (GCN5-related, putative) | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
NOX4 | NADPH oxidase 4 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
NPHS2 | Nephrosis 2, idiopathic, steroid-resistant (podocin) | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
OR2T10 | Olfactory receptor, family 2, subfamily T, member 10 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
PRR35 | Proline rich 35 | Predicted intracellular proteins
| | | | | Tissue enriched |
PTH1R | Parathyroid hormone 1 receptor | Disease related genes G-protein coupled receptors Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
PVALB | Parvalbumin | Predicted intracellular proteins
| | | | | Tissue enriched |
RAB11FIP3 | RAB11 family interacting protein 3 (class II) | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enriched |
RNF152 | Ring finger protein 152 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
SIM1 | Single-minded family bHLH transcription factor 1 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
SLC12A1 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC12A3 | Solute carrier family 12 (sodium/chloride transporter), member 3 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC13A3 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC16A12 | Solute carrier family 16, member 12 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC17A1 | Solute carrier family 17 (organic anion transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC17A3 | Solute carrier family 17 (organic anion transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A12 | Solute carrier family 22 (organic anion/urate transporter), member 12 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A13 | Solute carrier family 22 (organic anion/urate transporter), member 13 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A2 | Solute carrier family 22 (organic cation transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |